Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Pierre Bellier

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Alzheimer'S Research & Therapy|July 11, 2025
An improved immunoassay detects Aβ oligomers in human biofluids: their CSF levels rise with tau and phosphotau levelsTing Yang, Yi Ran Xu, Shanxue Jin, et al.
Cell Reports|June 30, 2026
Immunotherapy with B28, an antibody to Aβ oligomers, potently decreases amyloid plaques, microgliosis, and memory decline in APP knock-in miceTing Yang, Yi Ran Xu, Shaomin Li, et al.
Biorxiv : the Preprint Server for Biology|September 26, 2025
CNS-Tau Specific Antibodies Illuminate Disease Signatures Across TauopathiesLei Liu, Yin Zheng, Luke Slominski, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Identification of Fibrinogen as a Plasma Protein Binding Partner for Lecanemab Biosimilar IgG: Implications for Alzheimer's Disease TherapyJean-Pierre Bellier, Andrea Roman, Caitlyn Christiano, et al.
Annals of Clinical and Translational Neurology|October 30, 2024
Identification of fibrinogen as a plasma protein binding partner for lecanemab biosimilar IgGJean-Pierre Bellier, Andrea M Román Viera, Caitlyn Christiano, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 8, 2026
Identifying early changes in imaging, plasma, and digital cognitive biomarkers that correspond to Alzheimer's disease pathology in the presence of autopsy-confirmed co-pathologiesCharles D Chen, Cinthya Aguero, Alexandra Melloni, et al.
Nature Communications|April 14, 2026
Plasma phosphorylated tau 217 and longitudinal trajectories of Aβ, tau, and cognition in cognitively unimpaired older adultsHyun-Sik Yang, Juliana A U Anzai, Wai-Ying Wendy Yau, et al.
The Lancet. Neurology|July 29, 2024
γ-Secretase activity, clinical features, and biomarkers of autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analysis of the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS)Stephanie A Schultz, Lei Liu, Aaron P Schultz, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Alzheimer'S Research & Therapy|July 11, 2025
An improved immunoassay detects Aβ oligomers in human biofluids: their CSF levels rise with tau and phosphotau levelsTing Yang, Yi Ran Xu, Shanxue Jin, et al.
Cell Reports|June 30, 2026
Immunotherapy with B28, an antibody to Aβ oligomers, potently decreases amyloid plaques, microgliosis, and memory decline in APP knock-in miceTing Yang, Yi Ran Xu, Shaomin Li, et al.
Biorxiv : the Preprint Server for Biology|September 26, 2025
CNS-Tau Specific Antibodies Illuminate Disease Signatures Across TauopathiesLei Liu, Yin Zheng, Luke Slominski, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Identification of Fibrinogen as a Plasma Protein Binding Partner for Lecanemab Biosimilar IgG: Implications for Alzheimer's Disease TherapyJean-Pierre Bellier, Andrea Roman, Caitlyn Christiano, et al.
Annals of Clinical and Translational Neurology|October 30, 2024
Identification of fibrinogen as a plasma protein binding partner for lecanemab biosimilar IgGJean-Pierre Bellier, Andrea M Román Viera, Caitlyn Christiano, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 8, 2026
Identifying early changes in imaging, plasma, and digital cognitive biomarkers that correspond to Alzheimer's disease pathology in the presence of autopsy-confirmed co-pathologiesCharles D Chen, Cinthya Aguero, Alexandra Melloni, et al.
Nature Communications|April 14, 2026
Plasma phosphorylated tau 217 and longitudinal trajectories of Aβ, tau, and cognition in cognitively unimpaired older adultsHyun-Sik Yang, Juliana A U Anzai, Wai-Ying Wendy Yau, et al.
The Lancet. Neurology|July 29, 2024
γ-Secretase activity, clinical features, and biomarkers of autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analysis of the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS)Stephanie A Schultz, Lei Liu, Aaron P Schultz, et al.
Pageof 5